Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination).
about
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and preventionBreast Milk and Solid Food Shaping Intestinal ImmunityNew knowledge on pathogenesis of bacterial enteric infections as applied to vaccine developmentVibrio cholerae: lessons for mucosal vaccine design.Allele variants of enterotoxigenic Escherichia coli heat-labile toxin are globally transmitted and associated with colonization factors.Hemagglutination and intestinal adherence properties of clinical and environmental isolates of non-O1 Vibrio cholerae.Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis.Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.Molecular cloning and expression in Escherichia coli K-12 of the gene for a hemagglutinin from Vibrio choleraeWeak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients.Mapping of chromosomal genes that determine the El Tor biotype in Vibrio choleraeProtection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.Vibrio cholerae O1 adherence to villi and lymphoid follicle epithelium: in vitro model using formalin-treated human small intestine and correlation between adherence and cell-associated hemagglutinin levels.Purification of Vibrio cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations.
P2860
Q24530558-86B5A363-477B-4CFB-813C-EAAC2036B5C1Q26782801-43475BB6-725A-4A36-B10D-675AC85F9806Q33628356-0D3C7F2E-D067-4B06-A06B-22107C9448A6Q34562952-AC5BAC94-3A07-42C5-B135-854DE40E3566Q34746941-EDAA56BA-4013-4034-831A-078495627789Q36073627-6761E5F0-181E-480A-A93C-342325757665Q36975487-5F75B22C-139A-4618-B18D-31661AFC559FQ37018216-29EE3607-DA77-4F7F-9790-A131539D0064Q37054298-79DAFC90-31F1-4515-AF67-DA1431D88F85Q37079419-22B18EA6-DFF2-4B33-8DDF-8262C1C6CA02Q37100083-65904476-4F76-455C-80CC-F9807F0E6F90Q40152344-7A0949C1-596D-416E-8552-25676D6AD90EQ40159544-418F8814-176A-4DDF-8687-6234A942865BQ40183863-2EF5FF2A-D895-42E9-8C33-AE271AB3D848
P2860
Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination).
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@ast
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@en
type
label
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@ast
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@en
prefLabel
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@ast
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@en
P2860
P1476
Receptor-like glycocompounds i ...... adherence (hemagglutination).
@en
P2093
Lindblad M
P2860
P304
P407
P577
1983-01-01T00:00:00Z